Trexquant Investment’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $918K | Sell |
42,321
-179,499
| -81% | -$3.9M | 0.01% | 1128 |
|
|
2025
Q1 | $5.38M | Buy |
221,820
+15,331
| +7% | +$372K | 0.06% | 474 |
|
|
2024
Q4 | $4.31M | Sell |
206,489
-89,171
| -30% | -$1.86M | 0.05% | 575 |
|
|
2024
Q3 | $5.88M | Buy |
295,660
+174,931
| +145% | +$3.48M | 0.07% | 412 |
|
|
2024
Q2 | $1.87M | Buy |
120,729
+41,979
| +53% | +$650K | 0.03% | 783 |
|
|
2024
Q1 | $1.26M | Buy |
+78,750
| New | +$1.26M | 0.03% | 834 |
|
|
2023
Q1 | – | Sell |
-147,657
| Closed | -$2.75M | – | 1483 |
|
|
2022
Q4 | $2.75M | Sell |
147,657
-70,049
| -32% | -$1.3M | 0.08% | 322 |
|
|
2022
Q3 | $2.79M | Buy |
217,706
+130,755
| +150% | +$1.68M | 0.1% | 259 |
|
|
2022
Q2 | $610K | Buy |
86,951
+14,094
| +19% | +$98.9K | 0.03% | 714 |
|
|
2022
Q1 | $604K | Buy |
72,857
+20,888
| +40% | +$173K | 0.03% | 679 |
|
|
2021
Q4 | $352K | Buy |
+51,969
| New | +$352K | 0.02% | 834 |
|